SCHEMBL19786668

SCHEMBL19786668

c1ccc(-n2c3ccccc3c3c4c5ccc6ccccc6c5n(-c5ccc6c7ccccc7c7ccccc7c6c5)c4c4ccccc4c32)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.40
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CYP1A2 P05177 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
HPRT1 P00492 3/20 0.33
ALDH1A1 P00352 3/20 0.33
TSHR P16473 2/20 0.33
SIGMAR1 Q99720 1/20 0.32
MAPK1 P28482 1/20 0.32
KMT2A Q03164 2/20 0.32
MEN1 O00255 1/20 0.32
POLB P06746 1/20 0.32
BRCA1 P38398 1/20 0.32
HSD17B10 Q99714 1/20 0.32
GLA P06280 1/20 0.30
CYP3A4 P08684 1/20 0.30
HPGD P15428 1/20 0.30
MAPK8 P45983 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17123119 0.92 L3MBTL1 (0.42) KDM4EATML3MBTL1HPRT1ALDH1A1
SCHEMBL19786513 0.92 KDM4E (0.47) KDM4EATML3MBTL1CYP1A2CYP2C9
SCHEMBL19786512 0.88 ATM (0.35) KDM4EATML3MBTL1CYP1A2ALDH1A1
SCHEMBL18668064 0.87 KDM4E (0.45) KDM4EATML3MBTL1CYP1A2CYP2C9
SCHEMBL17071211 0.87 KDM4E (0.38) KDM4EATML3MBTL1ALDH1A1TSHR
SCHEMBL17123094 0.86 KDM4E (0.39) KDM4EATML3MBTL1ALDH1A1TSHR
SCHEMBL21108830 0.86 KDM4E (0.39) KDM4EATML3MBTL1CYP1A2CYP2C9
SCHEMBL18668065 0.86 KDM4E (0.46) KDM4EATML3MBTL1CYP1A2CYP2C9
SCHEMBL19786354 0.86 KDM4E (0.41) KDM4EATML3MBTL1SIGMAR1
SCHEMBL25098797 0.85 KDM4E (0.43) KDM4EATML3MBTL1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2019-10-03 US disclosed
WO-2018012781-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF ORC3, OR51E2, ORAI2 KDM4E 442/4885ATM 3467/4885L3MBTL1 1707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.